List of insiders holdings for CURIS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Aurigene Discovery Technologies Ltd DR REDDYS LABORATORIES LTD Dr. Reddy's Holdings Ltd 10% Owner |
2016-09-13 13:26:11 | 27,328,464 0 |
27,328,464 | Form 13G |
| 2 | MCNAB JAMES R Director |
2017-05-05 17:34:09 | 879,688 50,000 |
929,688 | Form 4/A |
| 3 | Fattaey Ali Ph.D. President & CEO |
2018-05-17 16:08:25 | 825,000 0 |
825,000 | Form 4 |
| 4 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC Indirect Beneficial Owner 10% Owner |
2021-02-11 16:43:23 | 626,945 0 |
626,945 | Form 13G |
| 5 | Tuck David Chief Medical Officer |
2018-05-17 16:11:44 | 535,000 0 |
535,000 | Form 4 |
| 6 | Mohindru Mani Chief Strategy Officer |
2017-02-16 16:36:38 | 424,000 0 |
424,000 | Form 4 |
| 7 | Steinkrauss William Chief Financial Officer |
2022-01-31 17:17:42 | 360,000 0 |
360,000 | Form 4 |
| 8 | Martell Robert Head of Research & Development |
2023-01-24 16:09:17 | 350,000 0 |
350,000 | Form 4 |
| 9 | MELTON DOUGLAS Director |
2006-08-24 10:30:08 | 163,499 0 |
163,499 | Form 4/A |
| 10 | Qian Changgeng VP, Research & Preclinical Dev |
2011-01-10 15:58:13 | 125,000 0 |
125,000 | Form 4 |
| 11 | Voi Maurizio Chief Medical Officer |
2013-01-18 16:19:26 | 125,000 0 |
125,000 | Form 4 |
| 12 | Pienta Kenneth Director |
2017-03-02 16:56:26 | 120,000 0 |
120,000 | Form 4 |
| 13 | MISSLING CHRISTOPHER U Sr. VP, Strategic Planning |
2004-01-21 17:22:53 | 104,600 0 |
104,600 | Form 4 |
| 14 | POTTHOFF MARY ELIZABETH VP and General Counsel |
2006-06-02 15:45:40 | 102,706 0 |
102,706 | Form 4 |
| 15 | RUBIN LEE L VP of Research |
2005-06-03 15:11:41 | 100,000 0 |
100,000 | Form 4 |
| 16 | Kunkel Lori Anne Director |
2022-01-31 17:33:15 | 85,000 0 |
85,000 | Form 4 |
| 17 | Viner Jaye Chief Medical Officer |
2015-05-28 16:06:39 | 80,000 0 |
80,000 | Form 4 |
| 18 | GRAY MICHAEL CFO |
2015-05-28 16:05:58 | 80,000 0 |
80,000 | Form 4 |
| 19 | Keegan Mitchell Vice-President |
2011-01-10 15:57:19 | 60,000 0 |
60,000 | Form 4 |
| 20 | PASSERI DANIEL R Director |
2016-01-21 16:20:38 | 50,000 0 |
50,000 | Form 4 |
| 21 | Dentzer James E President & CEO |
2025-01-30 16:10:09 | 40,000 0 |
40,000 | Form 4 |
| 22 | DAVIE JOSEPH M Director |
2007-06-08 14:06:49 | 35,000 0 |
35,000 | Form 4 |
| 23 | NOEL MARK VP, Tech Management |
2013-05-03 16:16:04 | 27,540 0 |
27,540 | Form 4 |
| 24 | TOBIN JAMES R Director |
2015-01-28 16:25:03 | 25,000 0 |
25,000 | Form 4 |
| 25 | BAYH SUSAN B Director |
2013-01-18 16:20:00 | 25,000 0 |
25,000 | Form 4 |
| 26 | DAVIE JOSEPH MD PHD Director |
2011-01-10 16:00:26 | 25,000 0 |
25,000 | Form 4 |
| 27 | CARTER STEPHEN Director |
2008-01-28 15:13:17 | 15,000 0 |
15,000 | Form 4 |
| 28 | Zung Jonathan B. CDO |
2025-01-30 16:08:56 | 15,000 0 |
15,000 | Form 4 |
| 29 | Duvall Diantha CFO |
2025-01-30 16:11:25 | 15,000 0 |
15,000 | Form 4 |
| 30 | KUNATH RUTH B Director |
2003-06-16 14:14:25 | 5,000 0 |
5,000 | Form 4 |
| 31 | GREENACRE MARTYN D Director |
2025-01-30 16:02:26 | 1,600 0 |
1,600 | Form 4 |
| 32 | Hohneker John Director |
2025-01-30 16:03:48 | 1,600 0 |
1,600 | Form 4 |
| 33 | Borgman Anne Elizabeth Director |
2025-01-30 16:05:28 | 1,600 0 |
1,600 | Form 4 |
| 34 | Rubin Marc Director |
2025-01-30 16:06:40 | 1,600 0 |
1,600 | Form 4 |
| 35 | KAITIN KENNETH I Director |
2025-01-30 16:07:46 | 1,600 0 |
1,600 | Form 4 |
| 36 | RA CAPITAL MANAGEMENT LLC RA Capital Biotech Fund LP RA Capital Biotech Fund II L.P. ALDRICH RICHARD Kolchinsky Peter 10% Owner |
2021-11-15 16:33:53 | 0 0 |
0 | Form 13G |